Computational optimization of delivery parameters to guide the development of targeted Nasal spray.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 03 2023
Historique:
received: 25 07 2022
accepted: 20 02 2023
entrez: 13 3 2023
pubmed: 14 3 2023
medline: 15 3 2023
Statut: epublish

Résumé

Airborne transmission by droplets and aerosols is known to play a critical role in the spread of many viruses amongst which are the common flu and the more recent SARS-CoV-2 viruses. In the case of SARS-CoV-2, the nasal cavity not only constitutes an important viral entry point, but also a primary site of infection (Sungnak W. et al. Nat. Med. 26:681-687. https://doi.org/10.1038/s41591-020-0868-6 , 2020).. Although face masks are a well-established preventive measure, development of novel and easy-to-use prophylactic measures would be highly beneficial in fighting viral spread and the subsequent emergence of variants of concern (Tao K. et al. Nat Rev Genet 22:757-773. https://doi.org/10.1038/s41576-021-00408-x , 2021). Our group has been working on optimizing a nasal spray delivery system that deposits particles inside the susceptible regions of the nasal cavity to act as a mechanical barrier to impede viral entry. Here, we identify computationally the delivery parameters that maximize the protection offered by this barrier. We introduce the computational approach and quantify the protection rate obtained as a function of a broad range of delivery parameters. We also introduce a modified design and demonstrate that it significantly improves deposition, thus constituting a viable approach to protect against nasal infection of airborne viruses. We then discuss our findings and the implications of this novel system on the prevention of respiratory diseases and targeted drug delivery.

Identifiants

pubmed: 36907909
doi: 10.1038/s41598-023-30252-4
pii: 10.1038/s41598-023-30252-4
pmc: PMC10008197
doi:

Substances chimiques

Nasal Sprays 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

4099

Informations de copyright

© 2023. The Author(s).

Références

Int J Pharm. 2020 Jan 25;574:118911
pubmed: 31809854
PLoS One. 2020 Aug 14;15(8):e0237691
pubmed: 32797067
Comput Biol Med. 2008 Jun;38(6):713-26
pubmed: 18468593
Nat Rev Genet. 2021 Dec;22(12):757-773
pubmed: 34535792
Cell. 2020 Jul 23;182(2):429-446.e14
pubmed: 32526206
Nat Rev Drug Discov. 2020 May;19(5):305-306
pubmed: 32273591
AAPS PharmSciTech. 2011 Mar;12(1):337-43
pubmed: 21286880
J Biomech. 2019 Mar 6;85:74-83
pubmed: 30685195
Sci Rep. 2020 Jun 15;10(1):9638
pubmed: 32541650
PLoS One. 2020 Aug 5;15(8):e0236063
pubmed: 32756567
Crit Rev Clin Lab Sci. 2020 Sep;57(6):365-388
pubmed: 32645276
Pharm Res. 2014 Aug;31(8):1930-7
pubmed: 24549819
Otolaryngol Head Neck Surg. 2021 Feb;164(2):305-307
pubmed: 33320052
Infect Dis Model. 2020 Apr 21;5:293-308
pubmed: 32355904
J Aerosol Med. 2007 Spring;20(1):59-74
pubmed: 17388754
Biotechnol Bioeng. 2009 Aug 1;103(5):936-43
pubmed: 19370772
Drug Deliv Transl Res. 2013 Feb;3(1):42-62
pubmed: 23316447
Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:4416-4419
pubmed: 34892199
Artif Organs. 2012 Apr;36(4):387-99
pubmed: 22145732
Environ Res. 2020 Sep;188:109819
pubmed: 32569870
Can J Anaesth. 2020 Sep;67(9):1217-1248
pubmed: 32542464
J R Soc Interface. 2011 Aug 7;8(61):1176-84
pubmed: 21300628
Infez Med. 2020 Jun 1;28(suppl 1):57-63
pubmed: 32532940
Sci Rep. 2020 Jun 29;10(1):10568
pubmed: 32601278
Int J Pharm. 2018 May 30;543(1-2):83-95
pubmed: 29597035
Signal Transduct Target Ther. 2020 Jul 25;5(1):128
pubmed: 32712629
ACS Nano. 2020 May 26;14(5):6339-6347
pubmed: 32329337
Pharm Res. 2011 Aug;28(8):1895-904
pubmed: 21499839
Curr Opin Virol. 2018 Feb;28:142-151
pubmed: 29452994
Nat Med. 2020 May;26(5):681-687
pubmed: 32327758
Adv Drug Deliv Rev. 1998 Jan 5;29(1-2):157-177
pubmed: 10837586
Med Devices Sens. 2021 Feb;4(1):e10163
pubmed: 33615150
Sci Rep. 2020 Feb 28;10(1):3755
pubmed: 32111935
Comput Biol Med. 2016 Oct 1;77:40-8
pubmed: 27509293

Auteurs

Jinze Du (J)

Department of Electrical Engineering, University of Southern California, Los Angeles, CA, 90089, USA. jinzedu@usc.edu.
Institute for Technology and Medical Systems Innovation (ITEMS), Keck School of Medicine, University of Southern California, Los Angeles, CA, 90089, USA. jinzedu@usc.edu.

Xiecheng Shao (X)

Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, 90089, USA.

Jean-Marie C Bouteiller (JC)

Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, 90089, USA.
Institute for Technology and Medical Systems Innovation (ITEMS), Keck School of Medicine, University of Southern California, Los Angeles, CA, 90089, USA.

Angela Lu (A)

Department of Pharmacy, University of Southern California, Los Angeles, CA, 90089, USA.

Isaac Asante (I)

Departments of Ophthalmology, University of Southern California, Los Angeles, CA, USA.
Institute for Technology and Medical Systems Innovation (ITEMS), Keck School of Medicine, University of Southern California, Los Angeles, CA, 90089, USA.
Roski Eye Institute, University of Southern California, Los Angeles, CA, USA.
Department of Pharmacy, University of Southern California, Los Angeles, CA, 90089, USA.

Stan Louie (S)

Departments of Ophthalmology, University of Southern California, Los Angeles, CA, USA.
Roski Eye Institute, University of Southern California, Los Angeles, CA, USA.
Department of Pharmacy, University of Southern California, Los Angeles, CA, 90089, USA.

Mark S Humayun (MS)

Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, 90089, USA.
Departments of Ophthalmology, University of Southern California, Los Angeles, CA, USA.
Roski Eye Institute, University of Southern California, Los Angeles, CA, USA.
USC Allen and Charlotte Ginsburg Institute for Biomedical Therapeutics, Los Angeles, CA, USA.

Gianluca Lazzi (G)

Department of Electrical Engineering, University of Southern California, Los Angeles, CA, 90089, USA.
Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, 90089, USA.
Departments of Ophthalmology, University of Southern California, Los Angeles, CA, USA.
Institute for Technology and Medical Systems Innovation (ITEMS), Keck School of Medicine, University of Southern California, Los Angeles, CA, 90089, USA.
Roski Eye Institute, University of Southern California, Los Angeles, CA, USA.
USC Allen and Charlotte Ginsburg Institute for Biomedical Therapeutics, Los Angeles, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH